Epigenomics: Licensee ARUP Laboratories Launches Septin9 Colorectal Cancer Blood Test in the United States
22-Jul-2010 -
Epigenomics AG reports that its licensee ARUP Laboratories, Salt Lake City, UT, U.S.A.,
today has announced the launched of a laboratory-developed test for the
blood-based detection of colorectal cancer. The test is based on
Epigenomics' proprietary Septin9 biomarker and DNA ...
biomarker
colorectal cancer